Quince Therapeutics, Inc. Earnings Per Share (Diluted)
Quince Therapeutics, Inc. (QNCX) reported Earnings Per Share (Diluted) of -$12.31 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-14
- Quince Therapeutics, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$12.31.
- Quince Therapeutics, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was $2.88.
- Quince Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.25.
- Quince Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$68.75.
- Quince Therapeutics, Inc. earnings per share, diluted for fiscal 2025 was -$1.68.
- Quince Therapeutics, Inc. earnings per share, diluted for fiscal 2024 was -$1.31.
- Quince Therapeutics, Inc. earnings per share, diluted for fiscal 2023 was -$0.84.
- Quince Therapeutics, Inc. earnings per share, diluted for fiscal 2022 was -$1.54.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$12.31 10-Q · filed 2026-08-14 | -$12.01 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | $2.88 10-Q · filed 2026-05-11 | |||||
| 2025-12-31 | -$1.68 10-K · filed 2026-04-10 | |||||
| 2025-09-30 | -$0.25 10-Q · filed 2025-11-12 | -$0.92 10-Q · filed 2025-11-12 | ||||
| 2025-06-30 | -$68.75 10-Q · filed 2026-08-14 | -$0.34 10-Q · filed 2025-08-11 | -$137.17 10-Q · filed 2026-08-14 | -$0.69 10-Q · filed 2025-08-11 | ||
| 2025-03-31 | -$3.42 10-Q · filed 2026-05-11 | -$0.34 10-Q · filed 2025-05-13 | ||||
| 2024-12-31 | -$1.31 10-K · filed 2026-04-10 | |||||
| 2024-09-30 | -$0.13 10-Q · filed 2025-11-12 | -$1.03 10-Q · filed 2025-11-12 | ||||
| 2024-06-30 | -$0.64 10-Q · filed 2025-08-11 | -$0.90 10-Q · filed 2025-08-11 | ||||
| 2024-03-31 | -$0.26 10-Q · filed 2025-05-13 | |||||
| 2023-12-31 | -$0.84 10-K · filed 2025-03-24 | |||||
| 2023-09-30 | -$0.15 10-Q · filed 2024-11-13 | -$0.63 10-Q · filed 2024-11-13 | ||||
| 2023-06-30 | -$0.14 10-Q · filed 2024-08-13 | -$0.48 10-Q · filed 2024-08-13 | ||||
| 2023-03-31 | -$0.34 10-Q · filed 2024-05-13 | |||||
| 2022-12-31 | -$1.54 10-K · filed 2024-04-01 | |||||
| 2022-09-30 | -$0.22 10-Q · filed 2023-11-14 | -$1.41 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | -$0.51 10-Q · filed 2023-08-03 | -$1.22 10-Q · filed 2023-08-03 | ||||
| 2022-03-31 | -$0.72 10-Q · filed 2023-05-15 | |||||
| 2021-12-31 | -$3.03 10-K · filed 2023-03-15 | |||||
| 2021-09-30 | -$0.73 10-Q · filed 2022-11-09 | -$2.25 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | -$0.74 10-Q · filed 2022-08-09 | -$1.52 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |